Press Releases

  January 26, 2012
NEW STORY CEL- SCI Corporation to Raise $5.76 Million in Registered Direct Offering
  January 20, 2012
NEW STORY CEL- SCI Corporation Releases Letter to Shareholders
  December 27, 2011
NEW STORY CEL- SCI Corporation Authorizes Expansion of Phase III Clinical Trial to an Additional 4 European Countries
  December 23, 2011
NEW STORY CEL-SCI Corporation Announces Fiscal 2011 Financial Results
  December 7, 2011
NEW STORY CEL- SCI Corporation Updates Phase III Clinical Activities for Investigational Cancer Therapy Multikine (Leukocyte Interleukin, Injection)
  November 2, 2011
NEW STORY CEL- SCI Corporation Updates Phase III Clinical Activities for Investigational Cancer Therapy Multikine (Leukocyte Interleukin, Injection)
  October 7, 2011
NEW STORY CEL-SCI Corporation Announces the Closing of Its $4 Million Registered Direct Offering of Common Stock and Warrants
  October 4, 2011
CEL-SCI Corporation to Raise $4 Million In Registered Direct Offering
  AUGUST 23, 2011
CEL-SCI Announces Exclusive Sales, Marketing and Distribution Agreement for Its Investigational Cancer Therapy Multikine (Leukocyte Interleukin, Injection) for Argentina and Venezuela
  AUGUST 18, 2011
CEL-SCI Addresses Warning Letter in Regard to Statements on Its Corporate Website
  AUGUST 17, 2011
CEL-SCI Receives Key Chinese Patent for Its Investigational Cancer Therapy Multikine (Leukocyte Interleukin, Injection)

 

 

News & Announcements

 

  

Sign Up For News